Rivaroxaban in the treatment of TEK‐related venous malformation
Sign Up to like & getrecommendations! Published in 2022 at "Australasian Journal of Dermatology"
DOI: 10.1111/ajd.13856
Abstract: Low‐flow vascular malformations are rare congenital anomalies due to errors in vascular development and may be associated with known pathogenic genetic variants. Slow flow through the blood vessels can lead to localized intralesional thromboses, which… read more here.
Keywords: rivaroxaban treatment; malformation; tek; venous malformation ... See more keywords
Rivaroxaban for the treatment of superficial vein thrombosis, experience at King’s College Hospital
Sign Up to like & getrecommendations! Published in 2021 at "British Journal of Haematology"
DOI: 10.1111/bjh.17757
Abstract: Paola Mariela Saba Villarroel Abdennour Amroun Marie Loosveld Xavier de Lamballerie Department of Pediatric Hematology, Immunology, and Oncology, APHM, La Timone Children’s Hospital, Aix Marseille Univ, INSERM, INRAe, C2VN, Unit e des Virus Emergents, UVE:… read more here.
Keywords: treatment superficial; rivaroxaban treatment; thrombosis experience; hematology ... See more keywords
Real-World Outcomes of Rivaroxaban Treatment in Patients with Both Nonvalvular Atrial Fibrillation and a History of Ischemic Stroke/Transient Ischemic Attack
Sign Up to like & getrecommendations! Published in 2019 at "Cerebrovascular Diseases"
DOI: 10.1159/000502883
Abstract: Introduction: Prior stroke is a risk factor for stroke and bleeding during anticoagulation in patients with atrial fibrillation (AF). Although rivaroxaban is widely prescribed to reduce their risk of stroke in patients with nonvalvular AF… read more here.
Keywords: stroke tia; ischemic stroke; prior ischemic; rivaroxaban treatment ... See more keywords
Rivaroxaban for the treatment of noncirrhotic splanchnic vein thrombosis: an interventional prospective cohort study.
Sign Up to like & getrecommendations! Published in 2022 at "Blood advances"
DOI: 10.1182/bloodadvances.2022007397
Abstract: Heparins and vitamin K antagonists are the mainstay of treatment for splanchnic vein thrombosis (SVT). Rivaroxaban is a potential alternative, but data to support its use are limited. We aimed to evaluate the safety and… read more here.
Keywords: treatment; rivaroxaban treatment; splanchnic vein; vein ... See more keywords
COSIMO – patients with active cancer changing to rivaroxaban for the treatment and prevention of recurrent venous thromboembolism: a non-interventional study
Sign Up to like & getrecommendations! Published in 2018 at "Thrombosis Journal"
DOI: 10.1186/s12959-018-0176-2
Abstract: BackgroundAround 20% of venous thromboembolism (VTE) cases occur in patients with cancer. Current guidelines recommend low molecular weight heparin (LMWH) as the preferred anticoagulant for VTE treatment. However, some guidelines state that vitamin K antagonists… read more here.
Keywords: vte; treatment; rivaroxaban treatment; cosimo ... See more keywords